Pathological Signal‐Responsive Nanoplatforms for Sepsis: Integrating Biomarker Sensing With Spatiotemporal Drug Delivery and Immunomodulation
{"Sepsis":[0],"remains":[1],"a":[2,24],"life-threatening":[3],"syndrome":[4],"characterized":[5],"by":[6,106,167],"dynamic":[7],"immune":[8],"dysregulation":[9],"and":[10,51,84,95,129,149],"multi-organ":[11],"failure.":[12],"Stimulus-responsive":[13],"nanoplatforms,":[14],"which":[15],"function":[16],"as":[17,23,43],"\\"biomarker-triggered\\"":[18],"therapeutic":[19,68,104],"systems,":[20],"have":[21],"emerged":[22],"frontier":[25],"in":[26,45,70,122],"precision":[27,174],"sepsis":[28,41,165],"management.":[29],"These":[30,158],"platforms":[31,102,152],"are":[32],"engineered":[33],"to":[34,153,163,172],"autonomously":[35],"sense":[36],"pathological":[37],"hallmarks":[38],"within":[39],"the":[40,80,119,130,141,161],"microenvironment-such":[42],"fluctuations":[44],"pH,":[46],"reactive":[47],"oxygen":[48],"species":[49],"(ROS),":[50],"specific":[52],"enzymatic":[53],"over-expression-thereby":[54],"enabling":[55],"precise,":[56],"spatiotemporal":[57],"drug":[58,109],"release.":[59],"Unlike":[60],"conventional":[61],"static":[62],"therapies,":[63],"these":[64,101],"\\"smart\\"":[65],"nanoplatforms":[66,87],"modulate":[67],"intervention":[69],"real-time":[71,144],"based":[72],"on":[73],"disease":[74],"progression.":[75],"This":[76],"review":[77],"comprehensively":[78],"evaluates":[79],"integration":[81],"of":[82,132,143],"sensing":[83],"therapy":[85],"using":[86],"loaded":[88],"with":[89],"antibiotics,":[90],"antimicrobial":[91],"peptides,":[92],"anti-inflammatory":[93],"agents,":[94],"gene-regulatory":[96],"molecules.":[97],"We":[98],"highlight":[99],"how":[100],"optimize":[103],"windows":[105],"enhancing":[107],"local":[108],"bioavailability":[110],"while":[111],"minimizing":[112],"systemic":[113],"off-target":[114],"toxicity.":[115],"Furthermore,":[116],"we":[117,136],"discuss":[118],"current":[120],"hurdles":[121],"clinical":[123],"translation,":[124],"including":[125],"patient-specific":[126],"biomarker":[127],"variability":[128],"complexity":[131],"scalable":[133],"fabrication.":[134],"Finally,":[135],"propose":[137],"future":[138],"directions,":[139],"emphasizing":[140],"synergy":[142],"biosensing,":[145],"artificial":[146],"intelligence":[147],"(AI),":[148],"multimodal":[150],"\\"theranostic\\"":[151],"achieve":[154],"stage-specific,":[155],"personalized":[156],"interventions.":[157],"advancements":[159],"hold":[160],"potential":[162],"redefine":[164],"management":[166],"shifting":[168],"from":[169],"\\"one-size-fits-all\\"":[170],"treatments":[171],"biomarker-driven":[173],"medicine.":[175]}
Authors
- Xuan Zhao (ORCID: https://orcid.org/0000-0002-4669-5149)
- Yu-Chang Wang (ORCID: https://orcid.org/0000-0003-0947-9823)
- Kang Wang (ORCID: https://orcid.org/0000-0002-4329-2272)
- Yukun Liu (ORCID: https://orcid.org/0000-0001-8135-131X)
- Xiangjun Bai (ORCID: https://orcid.org/0009-0003-4847-2285)
- Kwet Kyawl Yan
- Zhikai Xu (ORCID: https://orcid.org/0009-0009-3360-121X)
- Zhanfei Li
Institutions
- German Institute for Disaster Medicine (DE)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Advanced Science
- Published
- 2026-09-16
- DOI
- https://doi.org/10.1002/advs.77718
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Huazhong University of Science and Technology
- Natural Science Foundation of Hubei Province
- Tongji University
- Tongji Medical College, Huazhong University of Science and Technology